Abstracts & Informative Case Reports
WHO SHOULD SUBMIT
Abstract and Informative Case Report submission is open to physician-scientists, research scientists, clinicians and medical education professionals. This is a multi-disciplinary meeting; abstract submission is highly recommended for young investigators, fellows, junior scientists and trainees, who will benefit from close interaction with senior colleagues regarding his/her work. You may submit as many abstracts as you like; however only one abstract will be considered for an award.
Abstracts and Informative Case Reports must be submitted online via the CSCTR / MWAFMR abstract submission site. To ensure your data is entered correctly, follow all instructions carefully. Complete instructions for submission available online. When you completed the abstract submission process, print a copy of your submitted abstract for your files.
Abstract Example Case Report Example
All abstracts submitted will be graded by CSCTR / MWAFMR Midwest Clinical & Translational Research Meeting program committee members. The review process typically takes 2-3 weeks.
Abstract Categories / Informative Case Report Categories
Bone Marrow Transplant
Cardiology / Cardiovascular Disease
Diagnosis or Treatment of a Disease Process or Clinical Syndromes
Educational / Outcome Research
Endocrinology / Metabolism
Epidemiology / Health Outcomes / Quality Improvement / Bio-informatics
Gastroenterology / Clinical Nutrition
Genetic and Molecular Medicine
Hematology and Oncology
Pulmonary / Critical Care
Rheumatology / Immunology / Allergy
Other specialties also welcomed
There is a limit of 3,800 characters (including spaces) for the text of your abstract or informative case report submission. The character limit does not count authors, institutions, title or table(s).
AUTHOR ATTENDANCE REQUIREMENT
By submitting an abstract or informative case report to the Midwest Clinical & Translational Research Meeting, you agree that at least one author will attend the meeting if the abstract or informative case report is accepted. An author must be available to present on the date and time assigned by the Meeting program committee. Authors will be notified of presentation times at the time of, or shortly after, notification of acceptance and are expected to make appropriate travel arrangements to ensure that at least one author is present.
Only the abstract(s) of presenting authors who attended the meeting will be published in the Journal of Investigative Medicine (June issue). Abstract(s) of no show authors will not be published.